Jinhai Medical Technology Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	4.89	10.45	20.2	15.39	16.26	18.6
Short-Term Investments	-	2.33	3.34	3.08	0.92	0.22
Trading Asset Securities	2.08	4.48	6.56	7.59	8.74	7.14
Cash & Short-Term Investments	6.97	17.26	30.1	26.06	25.91	25.95
Cash Growth	-60.57%	-42.66%	15.51%	0.55%	-0.16%	17.34%
Accounts Receivable	4.32	4.86	5.53	2.21	1.46	2.28
Other Receivables	9.86	1.63	1.96	1.3	0.94	3.7
Receivables	14.17	6.6	7.61	3.51	2.44	6.01
Inventory	2.61	2.77	2.1	0.96	0.87	-
Prepaid Expenses	-	-	-	-	0.15	0.15
Other Current Assets	-	3.54	2.88	2.78	1.34	0.33
Total Current Assets	23.75	30.16	42.68	33.3	30.71	32.45
Property, Plant & Equipment	5.25	6.3	6.43	5.73	1.83	4.29
Long-Term Investments	0.52	0.56	0.56	-	-	-
Goodwill	0.52	0.52	-	-	-	-
Long-Term Deferred Tax Assets	0.01	0.02	0.04	0.16	0.19	0.21
Other Long-Term Assets	20.1	21.31	12.51	1.08	1.01	2.44
Total Assets	50.15	58.87	62.22	40.27	33.77	39.41
Accounts Payable	1.69	5.13	5.46	0.48	0.26	1.26
Accrued Expenses	-	3.54	4.57	4.52	4.53	4.24
Short-Term Debt	11.55	10.8	4.72	0.97	-	-
Current Portion of Leases	1	0.99	1.89	1.8	1.61	4.8
Current Income Taxes Payable	-	-	0.89	0.7	0.43	0.35
Current Unearned Revenue	1.93	1.36	0.53	2.09	1.2	1.24
Other Current Liabilities	4.08	1.54	3.19	3.45	1.43	1.28
Total Current Liabilities	20.25	23.36	21.25	14	9.47	13.17
Long-Term Debt	-	-	-	0.97	-	-
Long-Term Leases	2.13	2.73	3.48	0.71	0.25	0.71
Long-Term Deferred Tax Liabilities	-	-	-	-	0.03	0.05
Total Liabilities	22.38	26.09	24.73	15.68	9.75	13.92
Common Stock	2.25	2.25	2.25	2.14	2.14	2.14
Additional Paid-In Capital	32.32	32.32	32.32	14.96	14.96	14.96
Retained Earnings	-25.29	-16.29	1.68	6.12	5.65	7.01
Comprehensive Income & Other	18.08	13.52	1.23	1.15	1.52	1.37
Total Common Equity	27.36	31.81	37.47	24.37	24.28	25.49
Minority Interest	0.42	0.97	0.02	0.22	-0.25	-
Shareholders' Equity	27.78	32.78	37.49	24.59	24.02	25.49
Total Liabilities & Equity	50.15	58.87	62.22	40.27	33.77	39.41
Total Debt	14.67	14.52	10.08	4.45	1.87	5.5
Net Cash (Debt)	-7.7	2.73	20.01	21.61	24.04	20.45
Net Cash Growth	-	-86.34%	-7.37%	-10.14%	17.57%	70.02%
Net Cash Per Share	-0.00	0.00	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	5,170	5,170	5,170	4,920	4,920	4,920
Total Common Shares Outstanding	5,170	5,170	5,170	4,920	4,920	4,920
Working Capital	3.5	6.81	21.43	19.3	21.24	19.28
Book Value Per Share	0.01	0.01	0.01	0.00	0.00	0.01
Tangible Book Value	26.83	31.28	37.47	24.37	24.28	25.49
Tangible Book Value Per Share	0.01	0.01	0.01	0.00	0.00	0.01
Buildings	-	4.17	4.17	4.17	4.17	4.17
Machinery	-	3.4	1.83	4.6	2.08	2.44
Construction In Progress	-	-	1.64	0.99	0.25	-
Leasehold Improvements	-	2.99	1.93	1.96	1.7	2.27

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.